| Financial Year |
March 31 2023 |
| Monetary Funds |
2,197,329,071.00 |
| Held-for-trading Financial Assets |
4,145,294.50 |
| Notes Receivable |
455,170,479.50 |
| Accounts Receivable |
5,735,968,480.20 |
| Advances to Suppliers |
354,925,520.68 |
| Other Receivables |
39,149,362.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,774,731,809.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
54,084,931.51 |
| Other Current Assets |
517,865,978.43 |
| Total Current Assets |
12,915,051,772.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,817,070.04 |
| Investment Properties |
8,265,742.76 |
| Fixed Assetes |
14,332,002,890.23 |
| Under-construction Projects |
4,768,319,687.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,064,741,108.14 |
| R&D expenses |
-- |
| Goodwill |
520,230,679.65 |
| Long-Term Deferred and Prepaid Expenses |
1,135,099.33 |
| Deferred Income Tax Assets |
318,375,123.87 |
| Other Non-Current Assets |
4,227,665,117.56 |
| Sub-Total of Non-Current Assets |
25,359,108,250.43 |
| Total Assets |
38,274,160,023.05 |
| Short-Term Loans |
8,775,455,185.89 |
| Trading Financial liabilities |
94,394.79 |
| Notes Payable |
604,435,630.45 |
| Accounts Payable |
1,050,281,881.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
48,862,739.95 |
| Taxes Payable |
217,464,401.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
194,897,162.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
474,337,589.55 |
| Other Current Liabilities |
222,739,042.83 |
| Sub-Total of Current Liabilities |
11,624,271,384.31 |
| Long-term Loans |
4,940,109,097.02 |
| Bonds Payable |
428,896,518.67 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
236,688,342.51 |
| Other Non-Current Liabilities |
542,217,694.55 |
| Sub-Total of Non-Current Liabilities |
6,954,638,112.36 |
| Total Liabilities |
18,578,909,496.67 |
| Paid-In Capital(Or Share Stock) |
892,412,302.00 |
| Capital Surplus |
7,707,326,786.88 |
| Surplus Reserve |
191,644,843.59 |
| LESS:Treasury Stock |
101,753,346.66 |
| Undistributed Profits |
9,649,714,781.60 |
| Minority Stockholder's Interest |
1,280,819,174.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
18,414,431,351.94 |
| Owner's Equity（Stockholder's Equity） |
19,695,250,526.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
38,274,160,023.05 |
